Clinical pathways
125 results
101 - 125
Oral H1 antihistamines as ‘add‐on’ therapy to topical treatment for eczema- Antidepressants for the treatment of depression in people with cancer
- Targeted therapy for advanced renal cell carcinoma
- Pharmacological interventions for people with borderline personality disorder
- Psychosocial interventions for men with prostate cancer: Cochrane systematic review
- Speech and language therapy interventions for children with primary speech and language delay or disorder
- Probiotics for preventing gestational diabetes
- Specialist outreach clinics in primary care and rural hospital settings.
- Poly(ADP‐ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer
- Metformin for preventing the progression of chronic kidney disease
- Bisphosphonates and other bone agents for breast cancer: Cochrane systematic review
- Community-based population-level interventions for promoting child oral health: Cochrane systematic review
- Cephalomedullary nails versus extramedullary implants for extracapsular hip fractures in older adults
- Immunotherapy for metastatic renal cell carcinoma
- Antidepressants for smoking cessation
- Antioxidant supplementation for lung disease in cystic fibrosis
- School‐based self‐management interventions for asthma in children and adolescents: a mixed methods systematic review
- Primary‐level worker interventions for the care of people living with mental disorders and distress in low‐ and middle‐income countries
- Mechanical and surgical interventions for treating primary postpartum haemorrhage
- Omega‐3 fatty acid addition during pregnancy
- Splinting for the non‐operative management of developmental dysplasia of the hip (DDH) in children under six months of age
- Prostate MRI, with or without MRI‐targeted biopsy, and systematic biopsy for detecting prostate cancer
- Psychological interventions for parents of children and adolescents with chronic illness
- Antibody tests for identification of current and past infection with SARS‐CoV‐2
- Music therapy for people with substance use disorders